Literature DB >> 17353052

Reproducibility of macular thickness and volume using Zeiss optical coherence tomography in patients with diabetic macular edema.

Magdalena G Krzystolik, Samara F Strauber, Lloyd Paul Aiello, Roy W Beck, Brian B Berger, Neil M Bressler, David J Browning, Robert B Chambers, Ronald P Danis, Matthew D Davis, Adam R Glassman, Victor H Gonzalez, Paul B Greenberg, Jeffrey G Gross, Judy E Kim, Craig Kollman.   

Abstract

PURPOSE: To evaluate optical coherence tomography (OCT) reproducibility in patients with diabetic macular edema (DME).
DESIGN: Prospective 1-day observational study. PARTICIPANTS: Two hundred twelve eyes of 107 patients with DME involving the macular center by clinical examination and OCT central subfield thickness of > or =225 microm.
METHODS: Retinal thickness was measured with the OCT3 system, and scans were evaluated by a reading center. Reproducibility of retinal thickness measurements was assessed, and 95% confidence intervals (CIs) for a change in thickness were estimated. MAIN OUTCOME MEASURES: Reproducibility of OCT-measured central subfield thickness.
RESULTS: Reproducibility was better for central subfield thickness than for center point thickness (half-width of the 95% CI for absolute change, 38 microm vs. 50 microm, and for relative change, 11% vs. 17%, respectively; P<0.001). The median absolute difference between replicate measurements of the central subfield was 7 microm (2%). Half-widths of the 95% CI for a change in central subfield thickness were 22, 23, 33, and 56 microm for scans with central subfield thicknesses of <200, 200 to <250, 250 to <400, and > or =400 microm, respectively. When expressed as percentage differences between 2 measurements, half-widths of the 95% CI for a change in central subfield thickness were 10%, 10%, 10%, and 13% for scans with central subfield thicknesses of <200, 200 to <250, 250 to <400, and > or =400 microm, respectively. We were unable to identify an effect on reproducibility of central subfield measurements with respect to the presence of cystoid abnormalities, subretinal fluid, vitreomacular traction, or reduced visual acuity. Reproducibility was better when both scans had a standard deviation (SD) of the center point of <10.0% (half-width of the 95% CI for change, 33 microm vs. 56 microm; P<0.001).
CONCLUSIONS: Reproducibility is better for central subfield thickness measurements than for center point measurements, and variability is less with retinal thickness when expressed as a percent change than when expressed as an absolute change. A change in central subfield thickness exceeding 11% is likely to be real. Scans with an SD of the center point of > or =10.0% are less reproducible and should be viewed with caution when assessing the validity of an observed change in retinal thickness in patients with DME.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353052      PMCID: PMC2253719          DOI: 10.1016/j.ophtha.2006.10.055

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  5 in total

1.  Statistical methods for assessing agreement between two methods of clinical measurement.

Authors:  J M Bland; D G Altman
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

2.  Repeatability and reproducibility of fast macular thickness mapping with stratus optical coherence tomography.

Authors:  Antonio Polito; Michele Del Borrello; Miriam Isola; Nicola Zemella; Francesco Bandello
Journal:  Arch Ophthalmol       Date:  2005-10

3.  Reproducibility of retinal mapping using optical coherence tomography.

Authors:  P Massin; E Vicaut; B Haouchine; A Erginay; M Paques; A Gaudric
Journal:  Arch Ophthalmol       Date:  2001-08

4.  Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.

Authors:  David J Browning; Adam R Glassman; Lloyd Paul Aiello; Roy W Beck; David M Brown; Donald S Fong; Neil M Bressler; Ronald P Danis; James L Kinyoun; Quan Dong Nguyen; Abdhish R Bhavsar; Justin Gottlieb; Dante J Pieramici; Michael E Rauser; Rajendra S Apte; Jennifer I Lim; Päivi H Miskala
Journal:  Ophthalmology       Date:  2006-11-21       Impact factor: 12.079

5.  Intraobserver variability in optical coherence tomography.

Authors:  David J Browning; Christina M Fraser
Journal:  Am J Ophthalmol       Date:  2004-09       Impact factor: 5.258

  5 in total
  47 in total

1.  Factors associated with visual acuity outcomes after vitrectomy for diabetic macular edema: diabetic retinopathy clinical research network.

Authors:  Christina J Flaxel; Allison R Edwards; Lloyd Paul Aiello; Paul G Arrigg; Roy W Beck; Neil M Bressler; Susan B Bressler; Frederick L Ferris; Shailesh K Gupta; Julia A Haller; Howard S Lazarus; Haijing Qin
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

2.  Interpreting thickness changes in the diabetic macula: the problem of short-term variation in optical coherence tomography-measured macular thickening (an american ophthalmological society thesis).

Authors:  David J Browning
Journal:  Trans Am Ophthalmol Soc       Date:  2010-12

3.  Photobiomodulation in the treatment of patients with non-center-involving diabetic macular oedema.

Authors:  Johnny Tang; Ashley A Herda; Timothy S Kern
Journal:  Br J Ophthalmol       Date:  2014-03-28       Impact factor: 4.638

4.  A phase II randomized clinical trial of intravitreal bevacizumab for diabetic macular edema.

Authors:  Ingrid U Scott; Allison R Edwards; Roy W Beck; Neil M Bressler; Clement K Chan; Michael J Elman; Scott M Friedman; Craig Michael Greven; Raj K Maturi; Dante J Pieramici; Michel Shami; Lawrence J Singerman; Cynthia R Stockdale
Journal:  Ophthalmology       Date:  2007-08-15       Impact factor: 12.079

5.  Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspective.

Authors:  Adam R Glassman; Roy W Beck; David J Browning; Ronald P Danis; Craig Kollman
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

6.  Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.

Authors:  Farzin Forooghian; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

7.  Comparing central retinal thickness in diabetic macular edema measured by two different spectral-domain optical coherence tomography devices.

Authors:  Kiyoshi Suzuma; Yoshihisa Yamada; Michi Liu; Eiko Tsuiki; Azusa Fujikawa; Takashi Kitaoka
Journal:  Jpn J Ophthalmol       Date:  2011-09-03       Impact factor: 2.447

8.  The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.

Authors:  Amitha Domalpally; Barbara A Blodi; Ingrid U Scott; Michael S Ip; Neal L Oden; Andreas K Lauer; Paul C VanVeldhuisen
Journal:  Arch Ophthalmol       Date:  2009-11

9.  Relationship between photoreceptor outer segment length and visual acuity in diabetic macular edema.

Authors:  Farzin Forooghian; Paul F Stetson; Scott A Meyer; Emily Y Chew; Wai T Wong; Catherine Cukras; Catherine B Meyerle; Frederick L Ferris
Journal:  Retina       Date:  2010-01       Impact factor: 4.256

10.  Aqueous vascular endothelial growth factor as a predictor of macular thickening following cataract surgery in patients with diabetes mellitus.

Authors:  M Elizabeth Hartnett; Nicholas Tinkham; Lauren Paynter; Pete Geisen; Pinchas Rosenberg; Gary Koch; Kenneth L Cohen
Journal:  Am J Ophthalmol       Date:  2009-10-17       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.